دورية أكاديمية
SO-26 Intermittent or continuous panitumumab plus FOLFIRI for first-line treatment of patients with RAS/BRAF wild-type metastatic colorectal cancer: An update of survival/toxicity and preliminary results of genomic alterations from IMPROVE study
| العنوان: | SO-26 Intermittent or continuous panitumumab plus FOLFIRI for first-line treatment of patients with RAS/BRAF wild-type metastatic colorectal cancer: An update of survival/toxicity and preliminary results of genomic alterations from IMPROVE study |
|---|---|
| المؤلفون: | De Stefano, A., Giuliani, F., Nasti, G., Montesarchio, V., Santabarbara, G., Leo, S., Malapelle, U., Rosati, G., Lolli, I., Tamburini, E., Colombo, A., Santini, D., Silvestro, L., Leone, A., Vitagliano, C., Troncone, G., Sobrero, A., Giannarelli, D., Budillon, A., Avallone, A. |
| المساهمون: | Amgen |
| المصدر: | Annals of Oncology ; volume 34, page S172-S173 ; ISSN 0923-7534 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2023 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| مصطلحات موضوعية: | Oncology, Hematology |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1016/j.annonc.2023.04.498 |
| الإتاحة: | https://doi.org/10.1016/j.annonc.2023.04.498Test https://api.elsevier.com/content/article/PII:S0923753423006403?httpAccept=text/xmlTest https://api.elsevier.com/content/article/PII:S0923753423006403?httpAccept=text/plainTest |
| حقوق: | https://www.elsevier.com/tdm/userlicense/1.0Test/ |
| رقم الانضمام: | edsbas.1EAC5F77 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.annonc.2023.04.498 |
|---|